TrialCell reports. Medicine2025

Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.

Run-Cong Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.